TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The new capital is expected to fund the company through 2029
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Subscribe To Our Newsletter & Stay Updated
